ArticleJournal of fluorescence2025
Heterocyclic Coumarin Hybrids as Chemo Sensors of Neurotoxic Lead Ions in Safe Harmless Solvents and Ambient Temperature.
Article in Journal of fluorescence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Lead is a highly toxic poison for the human body. Lead poisoning is a fatal condition severely affecting the mental and physical development of children younger than 4-5 years. Among various chemo sensors, heterocyclic derivatives are widely used to chelate toxic metal ions, leading to changes in their optical, absorbance, and spectroscopic properties. In this study, coumarin heterocyclic hybrids C1-C6 were synthesized by reacting different classes of amine, pyrrole, and thiadiazoles with bromo acetyl coumarin at room temperature. The C1-C6 probes are studied for their metal binding ability in aqueous acetonitrile for Cu
Indexed as
Identifiers
39969712What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.